Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)

Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Molo 1 (also referred as GSP 301-2 NS);   Drug: Molo 2 (also referred as GSP 301-1 NS);   Drug: Placebo nasal spray;   Drug: DYMISTA nasal spray;   Drug: PATANASE nasal spray Sponsor:   Glenmark Pharmaceuticals Ltd. India Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials